Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'COMBINED HYPERLIPIDEMIA' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 442 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Burnett, TR; Watts, GF
      Therapeutic considerations for postprandial dyslipidaemia

      DIABETES OBESITY & METABOLISM
    2. Henriksen, FL; Petersen, PH; Beck-Nielsen, H; Horder, M
      Calibration, specificity and trueness of a postheparin plasma lipoprotein lipase assay

      CLINICAL CHEMISTRY AND LABORATORY MEDICINE
    3. Pallaud, C; Stranieri, C; Sass, C; Siest, G; Pignatti, F; Visvikis, S
      Candidate gene polymorphisms in cardiovascular disease: A comparative study of frequencies between a French and an Italian population

      CLINICAL CHEMISTRY AND LABORATORY MEDICINE
    4. Durrington, PN; Bhatnagar, D; Mackness, MI; Morgan, J; Julier, K; Khan, MA; France, M
      An omega-3 polyunsaturated fatty acid concentrate administered for one year decreased triglycerides in simvastatin treated patients with coronary heart disease and persisting hypertriglyceridaemia

      HEART
    5. Goldberg, IJ; Merkel, M
      Lipoprotein lipase: Physiology, biochemistry, and molecular biology

      FRONTIERS IN BIOSCIENCE
    6. Halkes, CJM; van Dijk, H; de Jaegere, PPT; Plokker, HWM; van der Helm, Y; Erkelens, DW; Cabezas, MC
      Postprandial increase of complement component 3 in normolipidemic patientswith coronary artery disease - Effects of expanded-dose simvastatin

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    7. Guerin, M; Le Goff, W; Lassel, TS; Van Tol, A; Steiner, G; Chapman, MJ
      Proatherogenic role of elevated CE transfer from HDL to VLDL1 and dense LDL in type 2 diabetes - Impact of the degree of triglyceridemia

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    8. Jiang, XC; Qin, SC; Qiao, CP; Kawano, K; Lin, M; Skold, A; Xiao, X; Tall, AR
      Apolipoprotein B secretion and atherosclerosis are decreased in mice with phospholipid-transfer protein deficiency

      NATURE MEDICINE
    9. Shek, A; Ferrill, MJ
      Statin-fibrate combination therapy

      ANNALS OF PHARMACOTHERAPY
    10. Marcus, A
      Current lipid-lowering strategies for the treatment of diabetic dyslipidemia: An integrated approach to therapy

      ENDOCRINOLOGIST
    11. Deighan, CJ; Caslake, MJ; McConnell, M; Boulton-Jones, JM; Packard, CJ
      Comparative effects of cerivastatin and fenofibrate on the atherogenic lipoprotein phenotype in proteinuric renal disease

      JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
    12. Shachter, NS
      Apolipoproteins C-I and C-III as important modulators of lipoprotein metabolism

      CURRENT OPINION IN LIPIDOLOGY
    13. Schmitz, G; Langmann, T
      Structure, function and regulation of the ABC1 gene product

      CURRENT OPINION IN LIPIDOLOGY
    14. Williams, KJ; Fisher, EA
      Atherosclerosis: cell biology and lipoproteins - Three distinct processes that control apolipoprotein-B secretion

      CURRENT OPINION IN LIPIDOLOGY
    15. Zietz, B; Barth, N; Scholmerich, J; Schmitz, G; Schaffler, A
      Gly15Gly polymorphism within the human adipocyte-specific apM-1gene but not Tyr111His polymorphism is associated with higher levels of cholesterol and LDL-cholesterol in caucasian patients with type 2 diabetes

      EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
    16. Cabezas, MC; Halkes, CJM; Erkelens, DW
      Obesity and free fatty acids: Double trouble

      NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
    17. Nordoy, A; Hansen, JB; Brox, J; Svensson, B
      Effects of atorvastatin and omega-3 fatty acids on LDL subfractions and postprandial hyperlipemia in patients with combined hyperlipemia

      NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
    18. Pajukanta, P; Bodnar, JS; Sallinen, R; Chu, M; Airaksinen, T; Xiao, QN; Castellani, LW; Sheth, SS; Wessman, M; Palotie, A; Sinsheimer, JS; Demant, P; Lusis, AJ; Peltonen, L
      Fine mapping of Hyplip1 and the human homolog, a potential locus for FCHL

      MAMMALIAN GENOME
    19. Insull, W; Kafonek, S; Goldner, D
      Translated Paper: Comparison of efficacy and safety of atorvastatin (10 mg) and simvastatin (10 mg) at six weeks.

      PERFUSION
    20. Ando, H; Nishimura, Y; Nemoto, T; Takamura, T; Nagai, Y; Kobayashi, K
      Severe hypercholesterolemia in a double heterozygote for lipoprotein lipase deficiency (LPLArita) and apolipoprotein epsilon(4): A report of a familywith LPLArita

      ENDOCRINE JOURNAL
    21. Keulen, ETP; Voors-Pette, C; de Bruin, TWA
      Familial dyslipidemic hypertension syndrome: Familial combined hyperlipidemia, and the role of abdominal fat mass

      AMERICAN JOURNAL OF HYPERTENSION
    22. Lau, TK; Leachman, DR; Lufschanowski, R
      Severe rhabdomyolysis associated with the cerivastatin-gemfibrozil combination therapy - Report of a case

      TEXAS HEART INSTITUTE JOURNAL
    23. Kuikka, JT; Raitakari, OT; Gould, KL
      Imaging of the endothelial dysfunction in coronary atherosclerosis

      EUROPEAN JOURNAL OF NUCLEAR MEDICINE
    24. Halkes, CJM; Cabezas, MC; van Wijk, JPH; Erkelens, DW
      Gender differences in diurnal triglyceridemia in lean and overweight subjects

      INTERNATIONAL JOURNAL OF OBESITY
    25. Schutte, BC; Carpten, JD; Forus, A; Gregory, SG; Horii, A; White, PS
      Report of the sixth international workshop on human chromosome 1 mapping 2000

      CYTOGENETICS AND CELL GENETICS
    26. Ozansoy, G; Akin, B; Aktan, F; Karasu, C
      Short-term gemfibrozil treatment reverses lipid profile and peroxidation but does not alter blood glucose and tissue antioxidant enzymes in chronically diabetic rats

      MOLECULAR AND CELLULAR BIOCHEMISTRY
    27. Viola, S; Benlian, P; Morali, A; Dobbelaere, D; Lacaille, F; Rieu, R; Ginies, EL; Maurage, C; Meyer, M; Lachaux, T; Larchet, M; Lenearts, C; Goulet, O; Sarles, J; Mouterde, O; Girardet, JP
      Apolipoprotein B Arg3500Gln mutation prevalence in children with hypercholesterolemia: A French multicenter study

      JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION
    28. Krauss, RM
      Dietary and genetic effects on low-density lipoprotein heterogeneity

      ANNUAL REVIEW OF NUTRITION
    29. Allayee, H; de Bruin, TWA; Dominguez, KM; Cheng, LSC; Ipp, E; Cantor, RM; Krass, KL; Keulen, ETP; Aouizerat, BE; Lusis, AJ; Rotter, JI
      Genome scan for blood pressure in Dutch dyslipidemic families reveals linkage to a locus on chromosome 4p

      HYPERTENSION
    30. Dayspring, TD
      Prevention of a first myocardial infarction

      JOURNAL OF CLINICAL PHARMACOLOGY
    31. Kobayashi, H; Nakamura, T; Miyaoka, K; Nishida, M; Funahashi, T; Yamashita, S; Matsuzawa, Y
      Visceral fat accumulation contributes to insulin resistance, small-sized low-density lipoprotein, and progression of coronary artery disease in middle-aged non-obese Japanese men

      JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION
    32. Pennacchio, LA; Olivier, M; Hubacek, JA; Cohen, JC; Cox, DR; Fruchart, JC; Krauss, RM; Rubin, EM
      An apolipoprotein influencing triglycerides in humans and mice revealed bycomparative sequencing

      SCIENCE
    33. Welch, CL; Bretschger, S; Latib, N; Bezouevski, M; Guo, Y; Pleskac, N; Liang, CP; Barlow, C; Dansky, H; Breslow, JL; Tall, AR
      Localization of atherosclerosis susceptibility loci to chromosomes 4 and 6using the Ldlr knockout mouse model

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    34. Kavazarakis, E; Moustaki, M; Gourgiotis, D; Drakatos, A; Bossios, A; Zeis, PM; Xatzidimoula, A; Karpathios, T
      Relation of serum leptin levels to lipid profile in healthy children

      METABOLISM-CLINICAL AND EXPERIMENTAL
    35. Otto, C
      Untitled - Reply

      METABOLISM-CLINICAL AND EXPERIMENTAL
    36. Aguilar-Salinas, CA; Fanghanel-Salmon, G; Meza, E; Montes, J; Gulias-Herrero, A; Sanchez, L; Monterrubio-Flores, EA; Gonzalez-Valdez, H; Perez, FJG
      Ciprofibrate versus gemfibrozil in the treatment of mixed hyperlipidemias:An open-label, multicenter study

      METABOLISM-CLINICAL AND EXPERIMENTAL
    37. Sheu, WHH; Jeng, CY; Lee, WJ; Lin, SY; Pei, D; Chen, YT
      Simvastatin treatment on postprandial hypertriglyceridemia in type 2 diabetes mellitus patients with combined hyperlipidemia

      METABOLISM-CLINICAL AND EXPERIMENTAL
    38. Dallinga-Thie, GM; Groenendijk, M; Blom, RNHHC; De Bruin, TWA; De Kant, E
      Genetic heterogeneity in the apolipoprotein C-III promoter and effects of insulin

      JOURNAL OF LIPID RESEARCH
    39. Redgrave, TG; Watts, GF; Martins, IJ; Barrett, PHR; Mamo, JCL; Dimmitt, SB; Marais, AD
      Chylomicron remnant metabolism in familial dyslipidemias studied with a remnant-like emulsion breath test

      JOURNAL OF LIPID RESEARCH
    40. Ko, C; Lee, TL; Lau, PW; Li, J; Davis, BT; Voyiaziakis, E; Allison, DB; Chua, SC; Huang, LS
      Two novel quantitative trait loci on mouse chromosomes 6 and 4 independently and synergistically regulate plasma apoB levels

      JOURNAL OF LIPID RESEARCH
    41. Escola-Gil, JC; Julve, J; Marzal-Casacuberta, A; Ordonez-Llanos, J; Gonzalez-Sastre, F; Blanco-Vaca, F
      ApoA-II expression in CETP transgenic mice increases VLDL production and impairs VLDL clearance

      JOURNAL OF LIPID RESEARCH
    42. Blanco-Vaca, F; Escola-Gil, JC; Martin-Campos, JM; Julve, J
      Role of apoA-II in lipid metabolism and atherosclerosis: advances in the study of an enigmatic protein

      JOURNAL OF LIPID RESEARCH
    43. McGladdery, SH; Frohlich, JJ
      Lipoprotein lipase and apoE polymorphisms: relationship to hypertriglyceridemia during pregnancy

      JOURNAL OF LIPID RESEARCH
    44. Meijssen, S; Cabezas, MC; Ballieux, CGM; Derksen, RJ; Bilecen, S; Erkelens, DW
      Insulin mediated inhibition of hormone sensitive lipase activity in vivo in relation to endogenous catecholamines in healthy subjects

      JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
    45. Schmidt, HHJ; Genschel, J; Baier, P; Schmidt, M; Ockenga, J; Tietge, UJF; Propsting, M; Buttner, C; Manns, MP; Lochs, H; Brabant, G
      Dyslipemia in familial partial lipodystrophy caused by an R482W mutation in the LMNA gene

      JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
    46. Groenendijk, M; De Bruin, TWA; Dallinga-Thie, GM
      Two polymorphisms in the apo A-IV gene and familial combined hyperlipidemia

      ATHEROSCLEROSIS
    47. Russo, GT; Meigs, JB; Cupples, LA; Demissie, S; Otvos, JD; Wilson, PWF; Lahoz, C; Cucinotta, D; Couture, P; Mallory, T; Schaefer, EJ; Ordovas, JM
      Association of the Sst-I polymorphism at the APOC3 gene locus with variations in lipid levels, lipoprotein subclass profiles and coronary heart disease risk: the Framingham offspring study

      ATHEROSCLEROSIS
    48. Groenendijk, M; Cantor, RM; de Bruin, TWA; Dallinga-Thie, GM
      The apoAI-CIII-AIV gene cluster

      ATHEROSCLEROSIS
    49. Athyros, VG; Papageorgiou, AA; Kontopoulos, AC
      Statin-fibrate combinations in patients with combined hyperlipidemia

      ATHEROSCLEROSIS
    50. Lahoz, C; Schaefer, EJ; Cupples, LA; Wilson, PWF; Levy, D; Osgood, D; Parpos, S; Pedro-Botet, J; Daly, JA; Ordovas, JM
      Apolipoprotein E genotype and cardiovascular disease in the Framingham Heart Study

      ATHEROSCLEROSIS
    51. Pihlajamaki, J; Valve, R; Karjalainen, L; Karhapaa, P; Vauhkonen, I; Laakso, M
      The hormone sensitive lipase gene in familial combined hyperlipidemia and insulin resistance

      EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
    52. Shike, T; Hirose, S; Kobayashi, M; Funabiki, K; Shirai, T; Tomino, Y
      Susceptibility and negative epistatic loci contributing to type 2 diabetesand related phenotypes in a KK/Ta mouse model

      DIABETES
    53. Kyrklund, C; Backman, JT; Kivisto, KT; Neuvonen, M; Laitila, J; Neuvonen, PJ
      Plasma concentrations of active lovastatin acid are markedly increased by gemfibrozil but not by bezafibrate

      CLINICAL PHARMACOLOGY & THERAPEUTICS
    54. Samuels, ME; Forbey, KC; Reid, JE; Abkevich, V; Bulka, K; Wardell, BR; Bowen, BR; Hopkins, PN; Hunt, SC; Ballinger, DG; Skolnick, MH; Wagner, S
      Identification of a common variant in the lipoprotein lipase gene in a large Utah kindred ascertained for coronary heart disease: the-93G/D9N variantpredisposes to low HDL-C/high triglycerides

      CLINICAL GENETICS
    55. Castilho, LN; Oliveira, HCF; Cazita, PM; de Oliveira, AC; Sesso, A; Quintao, ECR
      Oxidation of LDL enhances the cholesteryl ester transfer protein (CETP)-mediated cholesteryl ester transfer rate to HDL, bringing on a diminished nettransfer of cholesteryl ester from HDL to oxidized LDL

      CLINICA CHIMICA ACTA
    56. Marz, W; Scharnagl, H; Abletshauser, C; Hoffmann, MM; Berg, A; Keul, J; Wieland, H; Baumstark, MW
      Fluvastatin lowers atherogenic dense low-density lipoproteins in postmenopausal women with the atherogenic lipoprotein phenotype

      CIRCULATION
    57. Sniderman, AD; Scantlebury, T; Cianflone, K
      Hypertriglyceridemic hyperapoB: The unappreciated atherogenic dyslipoproteinemia in type 2 diabetes mellitus

      ANNALS OF INTERNAL MEDICINE
    58. Gilbert, B; Rouis, M; Griglio, S; de Lumley, L; Laplaud, PM
      Lipoprotein lipase (LPL) deficiency: a new patient homozygote for the preponderant mutation Gly188Glu in the human LPL gene and review of reported mutations: 75 % are clustered in exons 5 and 6

      ANNALES DE GENETIQUE
    59. Hegele, RA
      Monogenic dyslipidemias: Window on determinants of plasma lipoprotein metabolism

      AMERICAN JOURNAL OF HUMAN GENETICS
    60. Perola, M; Ohman, M; Hiekkalinna, T; Leppavuori, J; Pajukanta, P; Wessman, M; Koskenvuo, M; Palotie, A; Lange, K; Kaprio, J; Peltonen, L
      Quantitative-trait-locus analysis of body-mass index and of stature, by combined analysis of genome scans of five Finnish study groups

      AMERICAN JOURNAL OF HUMAN GENETICS
    61. Almario, RU; Vonghavaravat, V; Wong, R; Kasim-Karakas, SE
      Effects of walnut consumption on plasma fatty acids and lipoproteins in combined hyperlipidemia

      AMERICAN JOURNAL OF CLINICAL NUTRITION
    62. McKenney, JM; McCormick, LS; Schaefer, EJ; Black, DM; Watkins, ML
      Effect of niacin and atorvastatin on lipoprotein subclasses in patients with atherogenic dyslipidemia

      AMERICAN JOURNAL OF CARDIOLOGY
    63. Hopkins, PN; Stephenson, S; Wu, LL; Riley, WA; Xin, YP; Hunt, SC
      Evaluation of coronary risk factors in patients with heterozygous familialhypercholesterolemia

      AMERICAN JOURNAL OF CARDIOLOGY
    64. Insull, W; Kafonek, S; Goldner, D; Zieve, F
      Comparison of efficacy and safety of atorvastatin (10 mg) with simvastatin(10 mg) at six weeks

      AMERICAN JOURNAL OF CARDIOLOGY
    65. Miller, M; Dolinar, C; Cromwell, W; Otvos, JD
      Effectiveness of high doses of Simvastatin as monotherapy in mixed hyperlipidemia

      AMERICAN JOURNAL OF CARDIOLOGY
    66. Ginsberg, HN
      Hypertriglyceridemia: New insights and new approaches to pharmacologic therapy

      AMERICAN JOURNAL OF CARDIOLOGY
    67. Peltonen, L; Palotie, A; Lange, K
      Use of population isolates for mapping complex traits

      NATURE REVIEWS GENETICS
    68. Wu, LL; Hopkins, PN; Xin, YP; Stephenson, SH; Williams, RR; Nobe, Y; Kajita, M; Nakajima, T; Emi, M
      Co-segregation of elevated LDL with a novel mutation (D92K) of the LDL receptor in a kindred with multiple lipoprotein abnormalities

      JOURNAL OF HUMAN GENETICS
    69. Julve, J; Escola-Gil, JC; Marzal-Casacuberta, A; Ordonez-Llanos, J; Gonzalez-Sastre, F; Blanco-Vaca, F
      Increased production of very-low-density lipoproteins in transgenic mice overexpressing human apolipoprotein A-II and fed with a high-fat diet

      BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
    70. Busch, CP; Hegele, RA
      Variation of candidate genes in triglyceride metabolism

      JOURNAL OF CARDIOVASCULAR RISK
    71. Ginsberg, HN; Huang, LS
      The insulin resistance syndrome: impact on lipoprotein metabolism and atherothrombosis

      JOURNAL OF CARDIOVASCULAR RISK
    72. Rittershaus, CW; Miller, DP; Thomas, LJ; Picard, MD; Honan, CM; Emmett, CD; Pettey, CL; Adari, H; Hammond, RA; Beattie, DT; Callow, AD; Marsh, HC; Ryan, US
      Vaccine-induced antibodies inhibit CETP activity in vivo and reduce aorticlesions in a rabbit model of atherosclerosis

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    73. Pihlajamaki, J; Karjalainen, L; Karhapaa, P; Vauhkonen, I; Taskinen, MR; Deeb, SS; Laakso, M
      G-250A substitution in promoter of hepatic lipase gene is associated with dyslipidemia and insulin resistance in healthy control subjects and in members of families with familial combined hyperlipidemia

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    74. Walden, CE; Retzlaff, BM; Buck, BL; Wallick, S; McCann, BS; Knopp, RH
      Differential effect of National Cholesterol Education Program (NCEP) Step II diet on HDL cholesterol, its subfractions, and apoprotein A-I levels in hypercholesterolemic women and men after 1 year - The beFIT study

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    75. An, P; Rice, T; Gagnon, J; Borecki, IB; Bergeron, J; Despres, JP; Leon, AS; Skinner, JS; Wilmore, JH; Bouchard, C; Rao, DC
      Segregation analysis of apolipoproteins A-1 and B-100 measured before and after an exercise training program - The HERITAGE Family Study

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    76. de Man, FHAF; Jonkers, IJAM; Schwedhelm, E; Smelt, AHM; Onkenhout, W; van Duyvenvoorde, W; Buytenhek, R; Leuven, JAG; Troost, R; van der Laarse, A; Princen, HMG
      Normal oxidative stress and enhanced lipoprotein resistance to in vitro oxidation in hypertriglyceridemia - Effects of bezafibrate therapy

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    77. Pihlajamaki, J; Karjalainen, L; Karhapaa, P; Vauhkonen, I; Laakso, M
      Impaired free fatty acid suppression during hyperinsulinemia is a characteristic finding in familial combined hyperlipidemia, but insulin resistance is observed only in hypertriglyceridemic patients

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    78. Nordoy, A; Bonaa, KH; Sandset, PM; Hansen, JB; Nilsen, H
      Effect of omega-3 fatty acids and simvastatin on hemostatic risk factors and postprandial hyperlipemia in patients with combined hyperlipemia

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    79. Baum, L; Wiebusch, H; Pang, CP
      Roles for lipoprotein lipase in Alzheimer's disease: An association study

      MICROSCOPY RESEARCH AND TECHNIQUE
    80. Pignone, M; Phillips, C; Mulrow, C
      Use of lipid lowering drugs for primary prevention of coronary heart disease: meta-analysis of randomised trials

      BRITISH MEDICAL JOURNAL
    81. Smith, JL; Roach, PD; Wittenberg, LN; Riottot, M; Pillay, SP; Nestel, PJ; Nathanson, LK
      Effects of simvastatin on hepatic cholesterol metabolism, bile lithogenicity and bile acid hydrophobicity in patients with gallstones

      JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
    82. Klannemark, M; Suurinkeroinen, L; Orho-Melander, M; Groop, L; Taskinen, MR
      Interaction between the Asn291Ser variant of the LPL gene and insulin resistance on dyslipidaemia in high risk individuals for Type 2 diabetes mellitus

      DIABETIC MEDICINE
    83. Hall, S; Talmud, PJ; Cook, DG; Wicks, PD; Rothwell, RJ; Strazzullo, P; Sagnella, GA; Cappuccio, FP
      Frequency and allelic association of common variants in the lipoprotein lipase gene in different ethnic groups: The Wandsworth heart and stroke study

      GENETIC EPIDEMIOLOGY
    84. Kaufmann, PA; Gnecchi-Ruscone, T; Schafers, KP; Luscher, TF; Camici, PG
      Low density lipoprotein cholesterol and coronary microvascular dysfunctionin hypercholesterolemia

      JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    85. Razzaghi, H; Aston, CE; Hamman, RF; Kamboh, MI
      Genetic screening of the lipoprotein lipase gene for mutations associated with high triglyceride/low HDL-cholesterol levels

      HUMAN GENETICS
    86. van der Kallen, CJH; Cantor, RM; van Greevenbroek, MMJ; Geurts, JMW; Bouwman, FG; Aouizerat, BE; Allayee, H; Buurman, WA; Lusis, AJ; Rotter, JI; de Bruin, TWA
      Genome scan for adiposity in Dutch dyslipidemic families reveals novel quantitative trait loci for leptin, body mass index and soluble tumor necrosisfactor receptor superfamily 1A

      INTERNATIONAL JOURNAL OF OBESITY
    87. Milionis, HJ; Elisaf, MS; Mikhailidis, DP
      Treatment of dyslipidaemias in patients with established vascular disease:A revival of the fibrates

      CURRENT MEDICAL RESEARCH AND OPINION
    88. Cabezas, MC; Erkelens, DW
      Triglycerides and atherosclerosis: to feast or fast

      NETHERLANDS JOURNAL OF MEDICINE
    89. Perola, M; Kainulainen, K; Pajukanta, P; Terwilliger, JD; Hiekkalinna, T; Ellonen, P; Kaprio, J; Koskenvuo, M; Kontula, K; Peltonen, L
      Genome-wide scan of predisposing loci for increased diastolic blood pressure in Finnish siblings

      JOURNAL OF HYPERTENSION
    90. Toto, RD; Grundy, SM; Vega, GL
      Pravastatin treatment of very low density, intermediate density and low density lipoproteins in hypercholesterolemia and combined hyperlipidemia secondary to the nephrotic syndrome

      AMERICAN JOURNAL OF NEPHROLOGY
    91. Holm, C; Osterlund, T; Laurell, H; Contreras, JA
      Molecular mechanisms regulating hormone-sensitive lipase and lipolysis

      ANNUAL REVIEW OF NUTRITION
    92. Yang, HY; Rotter, JI
      The genetic background of inflammatory bowel disease

      HEPATO-GASTROENTEROLOGY
    93. Packard, C; Caslake, M; Shepherd, J
      The role of small, dense low density lipoprotein (LDL): a new look

      INTERNATIONAL JOURNAL OF CARDIOLOGY
    94. Pan, WJ; Gustavson, LE; Achari, R; Rieser, MJ; Ye, X; Gutterman, C; Wallin, BA
      Lack of a clinically significant pharmacokinetic interaction between fenofibrate and pravastatin in healthy volunteers

      JOURNAL OF CLINICAL PHARMACOLOGY
    95. Breslow, JL
      Genetics of lipoprotein abnormalities associated with coronary heart disease susceptibility

      ANNUAL REVIEW OF GENETICS
    96. Knopp, RH
      Introduction: Low-saturated fat, high-carbohydrate diets: Effects on triglyceride and LDL synthesis, the LDL receptor, and cardiovascular disease risk

      PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE
    97. Knopp, RH; Retzlaff, B; Walden, C; Fish, B; Buck, B; McCann, B
      One-year effects of increasingly fat-restricted, carbohydrate-enriched diets on lipoprotein levels in free-living subjects

      PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE
    98. Kiortsis, DN; Millionis, H; Bairaktari, E; Elisaf, MS
      Efficacy of combination of atorvastatin and micronised fenofibrate in the treatment of severe mixed hyperlipidemia

      EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
    99. Battula, SB; Fitzsimons, O; Moreno, S; Owens, D; Collins, P; Johnson, A; Tomkin, GH
      Postprandial apolipoprotein B48-and B100-containing lipoproteins in type 2diabetes: Do statins have a specific effect on triglyceride metabolism?

      METABOLISM-CLINICAL AND EXPERIMENTAL
    100. La, NA; Innis-Whitehouse, W; Li, XZ; Bakker-Arkema, R; Black, D; Brown, WV
      Lipid and apolipoprotein levels and distribution in patients with hypertriglyceridemia: Effect of triglyceride reductions with atorvastatin

      METABOLISM-CLINICAL AND EXPERIMENTAL


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 02/06/20 alle ore 02:36:59